$AGEN
AGENUS INC

2019 Q4 Form 10-K Financial Statement

#000156459020011221 Filed on March 16, 2020

View on sec.gov

Income Statement

Concept 2019 Q4 2018 Q4 2018 Q3
Revenue $34.50M $6.451M $12.80M
YoY Change 434.83% -22.78% 281.13%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $12.32M $9.720M $9.200M
YoY Change 26.75% -0.61% 14.29%
% of Gross Profit
Research & Development $36.83M $36.03M $29.85M
YoY Change 2.22% 13.05% 15.74%
% of Gross Profit
Depreciation & Amortization $1.660M $1.550M $1.630M
YoY Change 7.1% 6.9% 8.67%
% of Gross Profit
Operating Expenses $53.78M $45.88M $38.88M
YoY Change 17.22% 19.63% 11.02%
Operating Profit
YoY Change
Interest Expense -$11.85M -$8.730M -$7.540M
YoY Change 35.74% 71.18% 60.43%
% of Operating Profit
Other Income/Expense, Net $280.0K -$690.0K -$120.0K
YoY Change -140.58% -1250.0% -74.47%
Pretax Income -$30.85M -$48.85M -$33.73M
YoY Change -36.85% 39.45% -8.44%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$30.85M -$48.85M -$33.73M
YoY Change -36.84% 39.43% -8.44%
Net Earnings / Revenue -89.42% -757.22% -263.48%
Basic Earnings Per Share -$0.22
Diluted Earnings Per Share -$0.22 -$397.0K -$288.1K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $61.80M $53.10M $46.20M
YoY Change 16.38% -11.79% -34.09%
Cash & Equivalents $61.81M $53.05M $46.17M
Short-Term Investments
Other Short-Term Assets $1.015M $1.496M $15.30M
YoY Change -32.15% 38.26% 27.5%
Inventory $0.00 $55.00K $100.0K
Prepaid Expenses $7.420M $19.27M
Receivables $16.29M $938.0K $6.100M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $86.54M $74.81M $67.60M
YoY Change 15.68% 1.71% -19.81%
LONG-TERM ASSETS
Property, Plant & Equipment $26.33M $25.12M $25.80M
YoY Change 4.82% -4.06% 0.78%
Goodwill $23.19M $22.93M
YoY Change 1.15% -0.54%
Intangibles $10.50M $12.34M
YoY Change -14.86% -14.36%
Long-Term Investments
YoY Change
Other Assets $1.417M $1.214M $1.200M
YoY Change 16.72% -0.03% -7.69%
Total Long-Term Assets $68.80M $61.59M $62.90M
YoY Change 11.7% -5.02% -3.23%
TOTAL ASSETS
Total Short-Term Assets $86.54M $74.81M $67.60M
Total Long-Term Assets $68.80M $61.59M $62.90M
Total Assets $155.3M $136.4M $130.5M
YoY Change 13.88% -1.45% -12.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.56M $13.62M $11.10M
YoY Change -0.44% 68.47% 65.67%
Accrued Expenses $31.33M $24.55M $21.70M
YoY Change 27.62% 13.82% 5.34%
Deferred Revenue $29.17M $1.814M $843.2K
YoY Change 1508.27% -59.55%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $646.0K $146.0K $100.0K
YoY Change 342.47% -99.29% -99.5%
Total Short-Term Liabilities $122.2M $68.06M $58.20M
YoY Change 79.56% 20.6% 6.99%
LONG-TERM LIABILITIES
Long-Term Debt $13.38M $13.21M $13.10M
YoY Change 1.27% -90.72% -89.38%
Other Long-Term Liabilities $4.190M $2.773M $190.6M
YoY Change 51.1% -15.29% 721.55%
Total Long-Term Liabilities $17.57M $15.99M $203.7M
YoY Change 9.92% -89.03% 39.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $122.2M $68.06M $58.20M
Total Long-Term Liabilities $17.57M $15.99M $203.7M
Total Liabilities $139.8M $84.05M $260.9M
YoY Change 66.31% -58.41% 29.87%
SHAREHOLDERS EQUITY
Retained Earnings -$1.285B -$1.177B
YoY Change 9.15% 14.69%
Common Stock $1.378M $1.200M
YoY Change 14.83% 17.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$225.4M -$172.5M -$130.4M
YoY Change
Total Liabilities & Shareholders Equity $155.3M $136.4M $130.5M
YoY Change 13.88% -1.45% -12.59%

Cashflow Statement

Concept 2019 Q4 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income -$30.85M -$48.85M -$33.73M
YoY Change -36.84% 39.43% -8.44%
Depreciation, Depletion And Amortization $1.660M $1.550M $1.630M
YoY Change 7.1% 6.9% 8.67%
Cash From Operating Activities -$31.78M -$35.80M -$24.60M
YoY Change -11.23% 38.38% -5.93%
INVESTING ACTIVITIES
Capital Expenditures -$1.060M -$600.0K -$820.0K
YoY Change 76.67% -20.0% -14.58%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$1.060M -$600.0K -$820.0K
YoY Change 76.67% -114.15% -109.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.260M 43.42M 28.50M
YoY Change -97.1% 158.91% 6851.22%
NET CHANGE
Cash From Operating Activities -31.78M -35.80M -24.60M
Cash From Investing Activities -1.060M -600.0K -820.0K
Cash From Financing Activities 1.260M 43.42M 28.50M
Net Change In Cash -31.58M 6.900M 3.000M
YoY Change -557.68% -241.98% -117.96%
FREE CASH FLOW
Cash From Operating Activities -$31.78M -$35.80M -$24.60M
Capital Expenditures -$1.060M -$600.0K -$820.0K
Free Cash Flow -$30.72M -$35.20M -$23.78M
YoY Change -12.73% 40.13% -5.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Goodwill
Goodwill
23188000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10504000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1417000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61808000
CY2018Q4 us-gaap Inventory Net
InventoryNet
55000
CY2019Q4 us-gaap Assets
Assets
155335000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
646000
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
Lexington
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53054000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16293000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
938000
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7420000
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
19265000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1015000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1496000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
86536000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
74808000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26326000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25116000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7364000
CY2018Q4 us-gaap Goodwill
Goodwill
22925000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12338000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1214000
CY2018Q4 us-gaap Assets
Assets
136401000
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
3 Forbes Road
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02421
CY2019 dei City Area Code
CityAreaCode
781
CY2019 dei Local Phone Number
LocalPhoneNumber
674-4400
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity File Number
EntityFileNumber
000-29089
CY2019Q2 dei Entity Public Float
EntityPublicFloat
406800000
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2019 dei Security12b Title
Security12bTitle
Common Stock, $.01 Par Value
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
161589924
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
06-1562417
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
44919000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42877000
CY2018Q4 agen Liability Related To Sale Of Future Royalties And Milestones Payment Current
LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesPaymentCurrent
27443000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1814000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-640000
CY2019 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-41451000
CY2019 us-gaap Profit Loss
ProfitLoss
-111560000
CY2018 us-gaap Profit Loss
ProfitLoss
-162044000
CY2019 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
208000
CY2018 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2352000
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-120898000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6006000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
7625000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
12429000
CY2019 agen Non Cash Royalty Revenue
NonCashRoyaltyRevenue
30424000
CY2018 agen Non Cash Royalty Revenue
NonCashRoyaltyRevenue
17309000
CY2019 agen Non Cash Interest Expense
NonCashInterestExpense
42201000
CY2018 agen Non Cash Interest Expense
NonCashInterestExpense
24599000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
146000
CY2019Q4 agen Liability Related To Sale Of Future Royalties And Milestones Payment Current
LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesPaymentCurrent
45961000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
29174000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1347000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13624000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24551000
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
484000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
68062000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13380000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13212000
CY2019Q4 agen Liability Related To Sale Of Future Royalties And Milestones Payment Non Current
LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesPaymentNonCurrent
175408000
CY2018Q4 agen Liability Related To Sale Of Future Royalties And Milestones Payment Non Current
LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesPaymentNonCurrent
182817000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
27705000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1165000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8020000
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
3038000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2773000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
1378000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
1200000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1059583000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1005183000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1324000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1539000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1284993000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1177311000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-225356000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-172467000
CY2019Q4 us-gaap Minority Interest
MinorityInterest
-5981000
CY2018Q4 us-gaap Minority Interest
MinorityInterest
-2078000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-231337000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-174545000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
155335000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
136401000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
42861000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
38068000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9431000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7472000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
240000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
137818068
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
119996331
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36784000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
116125000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-70137000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
150048000
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-10767000
CY2018Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
14146000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
28000
CY2018 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-25273000
CY2017 us-gaap Profit Loss
ProfitLoss
-120692000
CY2018 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
207000
CY2017 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
206000
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3903000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-107865000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-159899000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.80
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.44
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.23
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
134982
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
110772
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
98415
CY2019 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
215000
CY2018 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
630000
CY2017 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-615000
CY2017 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
25000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
215000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
630000
CY2019 agen Comprehensive Income Loss Available To Common Stockholders Basic
ComprehensiveIncomeLossAvailableToCommonStockholdersBasic
-107650000
CY2018 agen Comprehensive Income Loss Available To Common Stockholders Basic
ComprehensiveIncomeLossAvailableToCommonStockholdersBasic
-159269000
CY2017 agen Comprehensive Income Loss Available To Common Stockholders Basic
ComprehensiveIncomeLossAvailableToCommonStockholdersBasic
-121538000
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-39126000
CY2017 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
-82000
CY2017 agen Stock Issued Under Stock Purchase Agreement Value
StockIssuedUnderStockPurchaseAgreementValue
60000000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10924000
CY2017 agen Reclassification Of Liability Classified Option Grants
ReclassificationOfLiabilityClassifiedOptionGrants
-2016000
CY2017 agen Vesting Of Nonvested Shares Value
VestingOfNonvestedSharesValue
-527000
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5560000
CY2017 agen Issuance Of Shares Related To Milestone Achievement Value
IssuanceOfSharesRelatedToMilestoneAchievementValue
1486000
CY2017 agen Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan
987000
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-75815000
CY2018 agen Minority Interest Increase From Distributions To Noncontrolling Interest Holders
MinorityInterestIncreaseFromDistributionsToNoncontrollingInterestHolders
274000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7351000
CY2018 agen Shares Issued To Consultants In Value
SharesIssuedToConsultantsInValue
50000
CY2018 agen Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan
1234000
CY2019 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
-25000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9892000
CY2019 agen Stock Issued Under Stock Purchase Agreement Value
StockIssuedUnderStockPurchaseAgreementValue
30000000
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
12962000
CY2019 agen Shares Issued To Consultants In Value
SharesIssuedToConsultantsInValue
81000
CY2019 agen Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan
StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan
1643000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6662000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6288000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
9892000
CY2017 agen Non Cash Interest Expense
NonCashInterestExpense
18242000
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-58000
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-145000
CY2017 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-24000
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
5805000
CY2018 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1335000
CY2017 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-3188000
CY2017 agen Gain On Issuance Of Stock For Settlement Of Milestone Obligation
GainOnIssuanceOfStockForSettlementOfMilestoneObligation
566000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15355000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-196000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10217000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-55000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-24000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9000
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-11792000
CY2018 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
8210000
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
8453000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-234000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5366000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1646000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
53900000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-397000
CY2017 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2722000
CY2019 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
7097000
CY2018 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
3303000
CY2017 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-4849000
CY2019 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1429000
CY2018 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
113000
CY2017 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
2329000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18682000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-131095000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-94226000
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
6000
CY2017 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
120000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4657000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3597000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3120000
CY2017 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
14936000
CY2017 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
20000000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4657000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3591000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2064000
CY2019 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
30000000
CY2018 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
44919000
CY2017 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
65560000
CY2019 agen Proceeds From Employee Stock Purchases And Option Exercises
ProceedsFromEmployeeStockPurchasesAndOptionExercises
1643000
CY2018 agen Proceeds From Employee Stock Purchases And Option Exercises
ProceedsFromEmployeeStockPurchasesAndOptionExercises
1234000
CY2017 agen Proceeds From Employee Stock Purchases And Option Exercises
ProceedsFromEmployeeStockPurchasesAndOptionExercises
987000
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
527000
CY2017 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
15000000
CY2017 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
150000
CY2018 agen Proceeds From Sale Of Future Royalties
ProceedsFromSaleOfFutureRoyalties
204878000
CY2018 agen Payments For Transaction Costs From Sale Of Future Royalties And Milestones
PaymentsForTransactionCostsFromSaleOfFutureRoyaltiesAndMilestones
494000
CY2018 us-gaap Repayments Of Debt
RepaymentsOfDebt
161847000
CY2019 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
320000
CY2018 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
283000
CY2017 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
331000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31323000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
128286000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
80539000
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
770000
CY2018 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-733000
CY2017 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
362000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8754000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7133000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11261000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53054000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
60187000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
71448000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
61808000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
1224000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
1171000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
1120000
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1242000
CY2018 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
300000
CY2017 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
968000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3017000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:2.27%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">(c) Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. We base those estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</p>
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
3700000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4349000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5278000
CY2019 agen Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions
-186000
CY2018 agen Unrecognized Tax Benefits Increases Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesDecreasesResultingFromPriorPeriodTaxPositions
7000
CY2017 agen Unrecognized Tax Benefits Decreases Resulting From Change In Federal Tax Rate
UnrecognizedTaxBenefitsDecreasesResultingFromChangeInFederalTaxRate
929000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4292000
CY2019Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
9575000
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
8770000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4314000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3528000
CY2019Q4 agen Accrued Contract Manufacturing Costs
AccruedContractManufacturingCosts
8768000
CY2019Q4 agen Accrued Research Services Current
AccruedResearchServicesCurrent
6675000
CY2018Q4 agen Accrued Research Services Current
AccruedResearchServicesCurrent
5348000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2000000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
958000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
240000000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2019 us-gaap Depreciation
Depreciation
4800000
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2019 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2019Q4 us-gaap Inventory Net
InventoryNet
0
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2018 us-gaap Depreciation
Depreciation
4300000
CY2018Q4 agen Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets Foreign
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssetsForeign
1063000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4882000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
264395000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
255066000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
262228000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
254315000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2167000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
751000
CY2019Q4 agen Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets Foreign
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssetsForeign
1009000
CY2017 us-gaap Depreciation
Depreciation
3800000
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
14146000
CY2019 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
100000
CY2018 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2200000
CY2017 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1900000
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
263000
CY2019 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
1945000
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
19935000
CY2018 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
1912000
CY2018Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
19810000
CY2019 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P9Y
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2300000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1900000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1900000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1900000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1400000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
300000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
69187000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
63184000
CY2019Q4 agen Deferred Tax Assets Operating Loss Carry Forwards Federal And State
DeferredTaxAssetsOperatingLossCarryForwardsFederalAndState
143126000
CY2018Q4 agen Deferred Tax Assets Operating Loss Carry Forwards Federal And State
DeferredTaxAssetsOperatingLossCarryForwardsFederalAndState
182557000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
4096000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
1524000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
16364000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
18507000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4774000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4824000
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
38710000
CY2018Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
36217000
CY2019Q4 agen Deferred Tax Assets Interest Expense Carryforward
DeferredTaxAssetsInterestExpenseCarryforward
3893000
CY2018Q4 agen Deferred Tax Assets Interest Expense Carryforward
DeferredTaxAssetsInterestExpenseCarryforward
6555000
CY2019Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
47456000
CY2019Q4 agen Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
2002000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3974000
CY2019Q4 agen Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
1599000
CY2019Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
165000
CY2018Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
406000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2773000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1469000
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
606000
CY2018Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
718000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-23413000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-34029000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-41035000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
7913000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
24233000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-63868000
CY2019 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-64000
CY2018 us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
7000
CY2018 agen Income Tax Reconciliation Foreign Income Inclusion
IncomeTaxReconciliationForeignIncomeInclusion
11089000
CY2019 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
4144000
CY2018 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
-11708000
CY2017 us-gaap Income Tax Reconciliation Tax Contingencies State And Local
IncomeTaxReconciliationTaxContingenciesStateAndLocal
-4561000
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
104764000
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-564000
CY2018 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
956000
CY2017 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
2084000
CY2019 agen Income Tax Reconciliation Income Tax Expense Benefit Change In Fair Value Of Contingent Consideration
IncomeTaxReconciliationIncomeTaxExpenseBenefitChangeInFairValueOfContingentConsideration
1219000
CY2018 agen Income Tax Reconciliation Income Tax Expense Benefit Change In Fair Value Of Contingent Consideration
IncomeTaxReconciliationIncomeTaxExpenseBenefitChangeInFairValueOfContingentConsideration
-280000
CY2017 agen Income Tax Reconciliation Income Tax Expense Benefit Change In Fair Value Of Contingent Consideration
IncomeTaxReconciliationIncomeTaxExpenseBenefitChangeInFairValueOfContingentConsideration
-1084000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
10765000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
9732000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4356000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
122000
CY2018Q4 agen Accrued Contract Manufacturing Costs
AccruedContractManufacturingCosts
5947000
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
530864
CY2017Q4 agen Common Stock Closing Price Per Share
CommonStockClosingPricePerShare
3.55
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.64
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.64
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.65
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.018
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.028
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
18613822
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
11579119
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
466940
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1186465
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1375389
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
27164147
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
27164147
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
11785971
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.15
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.00
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.15
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.20
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
5.08
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.67
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
79891000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15715000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19940000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
17435000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-51867000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-46277000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
18454000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-50686000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-45526000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
1400000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.67
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
4.33
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M24D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y7M24D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M29D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
19782605
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
19782605
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3677098
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.77
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.23
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.97
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
385000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
399000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
132000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2213967
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
737682
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
129675
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
702163
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2119811
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.20
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.98
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2.76
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
4.14
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.84
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
357000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
242000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
3800000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
53050
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1100000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9892000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7625000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12429000
CY2019Q4 agen Estimate Of Payments For Clinical Trials
EstimateOfPaymentsForClinicalTrials
319800000
CY2019 agen Clinical Trials Expense
ClinicalTrialsExpense
87700000
CY2018 agen Clinical Trials Expense
ClinicalTrialsExpense
41500000
CY2017 agen Clinical Trials Expense
ClinicalTrialsExpense
35800000
CY2019Q4 agen Cumulative Payments For Clinical Trials
CumulativePaymentsForClinicalTrials
239600000
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2052000
CY2019 agen Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
77000000
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
22638000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
56414000
CY2019Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
0
CY2019 agen Finance Lease Expiration Period
FinanceLeaseExpirationPeriod
2020
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
2551000
CY2019 agen Finance Lease Cost
FinanceLeaseCost
221000
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
1414000
CY2019 us-gaap Sublease Income
SubleaseIncome
561000
CY2019 us-gaap Lease Cost
LeaseCost
3625000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
9367000
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
796000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
148000
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
148000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2788000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2566000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1207000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
4384000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15721000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6354000
CY2019Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
159000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2614000
CY2019 us-gaap Lessee Operating Lease Lease Not Yet Commenced Description
LesseeOperatingLeaseLeaseNotYetCommencedDescription
These leases commenced in January 2020 with a term of 10 years.
CY2019Q4 us-gaap Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1
LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
P10Y
CY2019Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
159000
CY2019Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
11000
CY2019Q4 agen Expected Sublease Receipts Payments To Be Received Due Next Twelve Months
ExpectedSubleaseReceiptsPaymentsToBeReceivedDueNextTwelveMonths
578000
CY2019Q4 agen Expected Sublease Receipts Payments To Be Received
ExpectedSubleaseReceiptsPaymentsToBeReceived
578000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2162000
CY2019Q4 agen Net Future Lease Commitments Payments Due Next Twelve Months
NetFutureLeaseCommitmentsPaymentsDueNextTwelveMonths
2369000
CY2019Q4 agen Net Future Lease Commitments Payments Due Year Two
NetFutureLeaseCommitmentsPaymentsDueYearTwo
2566000
CY2019Q4 agen Net Future Lease Commitments Payments Due Year Three
NetFutureLeaseCommitmentsPaymentsDueYearThree
2614000
CY2019Q4 agen Net Future Lease Commitments Payments Due Year Four
NetFutureLeaseCommitmentsPaymentsDueYearFour
2162000
CY2019Q4 agen Net Future Lease Commitments Payments Due Year Five
NetFutureLeaseCommitmentsPaymentsDueYearFive
1207000
CY2019Q4 agen Net Future Lease Commitments Payments Due After Year Five
NetFutureLeaseCommitmentsPaymentsDueAfterYearFive
4384000
CY2019Q4 agen Net Future Lease Commitments Payments Due
NetFutureLeaseCommitmentsPaymentsDue
15302000
CY2019Q4 agen Lessee Operating Lease Lease Not Yet Commenced Future Minimum Payments
LesseeOperatingLeaseLeaseNotYetCommencedFutureMinimumPayments
14900000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-33731000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-48848000
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-54192000
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24723000
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33177000
CY2018Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-47807000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.53
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y2M12D
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.166
CY2019Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
120000
CY2018Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
788000
CY2019Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
14026000
CY2018Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
13358000
CY2018Q4 agen Liability Related To Sale Of Future Royalties And Milestones Including Unamortized Transaction Costs
LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesIncludingUnamortizedTransactionCosts
210795000
CY2019 agen Noncash Royalty Revenue Recognized
NoncashRoyaltyRevenueRecognized
30424000
CY2019 agen Non Cash Interest Expense Related To Sale Of Future Royalties
NonCashInterestExpenseRelatedToSaleOfFutureRoyalties
41474000
CY2019Q4 agen Liability Related To Sale Of Future Royalties And Milestones Including Unamortized Transaction Costs
LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesIncludingUnamortizedTransactionCosts
221845000
CY2019Q4 agen Liability Related To Sale Of Future Royalties Unamortized Transaction Costs
LiabilityRelatedToSaleOfFutureRoyaltiesUnamortizedTransactionCosts
476000
CY2019Q4 agen Liability Related To Sale Of Future Royalties And Milestones Net
LiabilityRelatedToSaleOfFutureRoyaltiesAndMilestonesNet
221369000
CY2019Q4 agen Contingent Consideration Liability Fair Value Disclosure
ContingentConsiderationLiabilityFairValueDisclosure
8843000
CY2019Q4 us-gaap Nonfinancial Liabilities Fair Value Disclosure
NonfinancialLiabilitiesFairValueDisclosure
8843000
CY2018Q4 agen Contingent Consideration Liability Fair Value Disclosure
ContingentConsiderationLiabilityFairValueDisclosure
3038000
CY2018Q4 us-gaap Nonfinancial Liabilities Fair Value Disclosure
NonfinancialLiabilitiesFairValueDisclosure
3038000
CY2019Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
922000
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
617000
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
487000
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
922000
CY2018 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
617000
CY2017 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
487000
CY2019Q4 us-gaap Noncurrent Assets
NoncurrentAssets
27743000
CY2018Q4 us-gaap Noncurrent Assets
NoncurrentAssets
26330000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34502000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-30851000
CY2019Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30107000
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1636000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15895000
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12802000
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6451000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-54261000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-25204000
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37

Files In Submission

Name View Source Status
0001564590-20-011221-index-headers.html Edgar Link pending
0001564590-20-011221-index.html Edgar Link pending
0001564590-20-011221.txt Edgar Link pending
0001564590-20-011221-xbrl.zip Edgar Link pending
agen-10k_20191231.htm Edgar Link pending
agen-20191231.xml Edgar Link completed
agen-20191231.xsd Edgar Link pending
agen-20191231_cal.xml Edgar Link unprocessable
agen-20191231_def.xml Edgar Link unprocessable
agen-20191231_lab.xml Edgar Link unprocessable
agen-20191231_pre.xml Edgar Link unprocessable
agen-ex10101_179.htm Edgar Link pending
agen-ex10102_177.htm Edgar Link pending
agen-ex10103_178.htm Edgar Link pending
agen-ex211_7.htm Edgar Link pending
agen-ex231_11.htm Edgar Link pending
agen-ex311_14.htm Edgar Link pending
agen-ex312_8.htm Edgar Link pending
agen-ex321_6.htm Edgar Link pending
agen-ex412_180.htm Edgar Link pending
agen-ex47_181.htm Edgar Link pending
agen-ex48_182.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
grsl10rcfjug000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending